Long Ma

1.1k total citations
25 papers, 522 citations indexed

About

Long Ma is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Long Ma has authored 25 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Long Ma's work include Gastric Cancer Management and Outcomes (6 papers), Metastasis and carcinoma case studies (5 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). Long Ma is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Metastasis and carcinoma case studies (5 papers) and Osteoarthritis Treatment and Mechanisms (4 papers). Long Ma collaborates with scholars based in China, United States and Canada. Long Ma's co-authors include Feng Gao, Guangming Lu, Hua Yang, Qing Miao, Peng Wang, Jie Zhang, Jonathan M. Kurie, Shailaja Kalyankrishna, Babita Saigal and Wei Wei and has published in prestigious journals such as Molecular and Cellular Biology, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Long Ma

23 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Long Ma China 11 221 149 136 90 54 25 522
Qingshou Chen United States 12 90 0.4× 113 0.8× 62 0.5× 46 0.5× 26 0.5× 15 386
Linyi Liu China 14 191 0.9× 103 0.7× 72 0.5× 20 0.2× 23 0.4× 31 395
Patrick Cohen France 12 135 0.6× 49 0.3× 209 1.5× 141 1.6× 83 1.5× 26 556
Catherine J. Drummond United Kingdom 14 248 1.1× 51 0.3× 159 1.2× 93 1.0× 14 0.3× 24 452
Seraina Faes Switzerland 12 370 1.7× 27 0.2× 156 1.1× 68 0.8× 32 0.6× 23 628
Zhongzheng Lu China 11 392 1.8× 40 0.3× 121 0.9× 36 0.4× 15 0.3× 11 642
Sylvie Lehmann Switzerland 11 330 1.5× 90 0.6× 183 1.3× 11 0.1× 35 0.6× 12 623
Po-Hsien Huang Taiwan 13 460 2.1× 74 0.5× 139 1.0× 39 0.4× 15 0.3× 30 639
Chi‐Wei Chen Taiwan 11 278 1.3× 112 0.8× 88 0.6× 37 0.4× 31 0.6× 27 452

Countries citing papers authored by Long Ma

Since Specialization
Citations

This map shows the geographic impact of Long Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long Ma more than expected).

Fields of papers citing papers by Long Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long Ma. The network helps show where Long Ma may publish in the future.

Co-authorship network of co-authors of Long Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Long Ma. A scholar is included among the top collaborators of Long Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long Ma. Long Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Qi, Gang Wu, Zhi‐Rong Chen, et al.. (2025). Mechanism of ITGB2 in Osteoclast Differentiation in Osteoarthritis. Cell Proliferation. 59(3). e70107–e70107. 1 indexed citations
2.
Yang, Yang, Qi Ma, Gang Wu, et al.. (2025). Tcirg1 deficiency delays osteoarthritis progression by impairing lysosome acidification and peripheral accumulation in osteoclasts. Frontiers in Cell and Developmental Biology. 13. 1621648–1621648.
3.
Zhu, Chen, Long Ma, Xuehua Chen, et al.. (2025). Bladder Stone Composition in Jiangsu Region of China: Results from 421 Stone Analyses. Urologia Internationalis. 109(6). 590–595.
4.
Guo, Feilong, Guoli Li, Long Ma, et al.. (2023). Efficacy of intra-arterial chemotherapy with sequential anti-PD-1 antibody in unresectable gastric cancer: A retrospective real-world study. Frontiers in Oncology. 12. 1015962–1015962. 8 indexed citations
5.
Guo, Feilong, Yuhua Huang, Long Ma, et al.. (2023). Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy. International Journal of Clinical Oncology. 28(9). 1158–1165. 3 indexed citations
6.
Ma, Long, et al.. (2022). FAPI PET/CT in the Diagnosis of Abdominal and Pelvic Tumors. Frontiers in Oncology. 11. 797960–797960. 22 indexed citations
7.
Ghione, Paola, M. Lia Palomba, Hervé Ghesquières, et al.. (2022). Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study. Haematologica. 108(3). 822–832. 21 indexed citations
8.
Ma, Long, et al.. (2021). The role of lumbosacral innervating noradrenergic neurons in micturition control. Brain Research. 1777. 147754–147754. 1 indexed citations
9.
Hu, Xueyu, et al.. (2021). The protective mechanism of SIRT1 on cartilage through regulation of LEF-1. BMC Musculoskeletal Disorders. 22(1). 642–642. 6 indexed citations
10.
Chen, Zhirong, Haohui Guo, Zheng Wang, et al.. (2021). Extensive cytokine analysis in synovial fluid of osteoarthritis patients. Cytokine. 143. 155546–155546. 23 indexed citations
11.
Li, Guoli, et al.. (2020). Phase II Study of Preoperative Intra-Arterial Epirubicin, Etoposide, and Oxaliplatin Combined with Oral S-1 Chemotherapy for the Treatment of Borrmann Type 4 Gastric Cancer. Journal of the Korean Gastric Cancer Association. 20(4). 395–395. 6 indexed citations
13.
Gao, Feng, Zijian Chen, Long Ma, et al.. (2019). Benzofuran-isatin hybrids tethered via different length alkyl linkers and their in vitro anti-mycobacterial activities. Bioorganic & Medicinal Chemistry. 27(12). 2652–2656. 8 indexed citations
14.
Gao, Feng, Peng Wang, Hua Yang, et al.. (2018). Recent developments of quinolone-based derivatives and their activities against Escherichia coli. European Journal of Medicinal Chemistry. 157. 1223–1248. 90 indexed citations
15.
Gao, Feng, Hua Yang, Tianyu Lu, et al.. (2018). Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybrids. European Journal of Medicinal Chemistry. 159. 277–281. 65 indexed citations
16.
He, Qi, Long Ma, Yang Li, & Guoli Li. (2016). A pilot study of an individualized comprehensive treatment for advanced gastric cancer with para-aortic lymph node metastasis. BMC Gastroenterology. 16(1). 8–8. 9 indexed citations
17.
He, Qi, Yang Li, Long Ma, Xiang Ji, & Guoli Li. (2016). Application of FLEEOX Preoperative Chemotherapy via Intra-arterial and Intravenous Administration in Treatment of Unresectable Locally Advanced Gastric Cancer. Journal of Gastrointestinal Surgery. 20(8). 1421–1427. 12 indexed citations
18.
Zhao, Min, Jianbo Chen, Wanyin Wang, et al.. (2008). Psychological stress induces hypoferremia through the IL-6–hepcidin axis in rats. Biochemical and Biophysical Research Communications. 373(1). 90–93. 36 indexed citations
19.
Zhang, Jie, Shailaja Kalyankrishna, Marie Wislez, et al.. (2007). Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines. American Journal Of Pathology. 170(1). 366–376. 130 indexed citations
20.
Chou, Chung‐Kwang, Neil M. Vora, K.H. Luk, et al.. (1998). A Pilot Study of Intracavitary Hyperthermia Combined with Radiation in the Treatment of Oesophageal Carcinoma. International Journal of Hyperthermia. 14(3). 245–254. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026